Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene.
about
Pre-existing vector immunity does not prevent replication deficient adenovirus from inducing efficient CD8 T-cell memory and recall responsesProtection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques.Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccinesSignature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.Enhancement of SIV-specific cell mediated immune responses by co-administration of soluble PD-1 and Tim-3 as molecular adjuvants in mice.The influence of delivery vectors on HIV vaccine efficacyPotent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28.Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili studyNeutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccineHuman immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypesRegulation of SIV antigen-specific CD4+ T cellular immunity via autophagosome-mediated MHC II molecule-targeting antigen presentation in mice.Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adultsProtective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.Development of nonhuman adenoviruses as vaccine vectors.Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron ABaculovirus vectors elicit antigen-specific immune responses in micePhase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorRobust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.Recent advances in delivery systems for anti-HIV1 therapy.Current progress of DNA vaccine studies in humans.Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles.Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus VaccinesHeterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors.Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines.Chimpanzee-origin adenovirus vectors as vaccine carriers.Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-cell responses in mice.
P2860
Q27304910-A93AF505-3EEF-45F1-A825-8D3CC34D6CF6Q30401519-1A4DCC37-1F03-4AB3-BE25-0BECD7E290C2Q33268303-EB819FD7-E967-47E2-9D0C-DF65A4509458Q33424498-94B0BBAD-2114-46F5-9019-F01DD2B2B6A7Q33737811-36F3E321-1F40-4A77-9E93-998B23CDB060Q33984182-CB2E1B33-A011-406C-8EE8-D5976232E77DQ34033862-35F8FF63-8EA8-4EFA-95B7-0C5D5D3B4025Q34077543-4629DDFF-7956-4D3B-AC9A-90956B9905F9Q34081164-599CC72C-4A19-468C-806A-CE8C16F62AD0Q34240204-CB34FA97-1957-42D7-B1E0-39092DA662D5Q35082956-E03DF50B-DD1B-444A-81AC-1E6CDDE0311BQ35123692-3F3F8937-7A2D-42B8-8405-A7E531DFE77BQ35132375-75B2F5A4-FF33-46D4-B755-7736F23C1514Q35667935-80468CE7-8E1E-47B2-8414-6AF9FCD17483Q36315185-C48FC013-D903-421A-ABDB-D83283A7DB56Q36317264-98CABAEA-EBEF-4F43-AA5B-D03F815559DEQ36540068-CAF71E0D-5071-472E-B5AB-5A9380E9A02DQ36684637-3BD636AC-49FB-4908-B24D-2616704CE888Q36720991-BEAB7CC7-D870-4A6F-9F68-18EF33FBD255Q36759963-272E5FEB-8D0E-4B10-A869-B8D42A735769Q36761854-EACB2527-3B01-4AF7-B9DB-278D8A19C047Q37103923-747FB612-3055-4876-AFB4-1827A3197EC9Q37461371-AFC76A13-DD83-4141-A00E-310660536B3CQ37730793-1E4E1F30-3D7B-4177-B964-B5BCD9588F81Q37742938-143A3832-866E-4F2A-A3F6-DFBD383B4922Q39582556-0D375D39-1DEC-4B58-99E9-995F5687616EQ40162047-3BC9C54C-1E4B-4B49-95CD-59F1A91AAC8AQ40263989-D1FA04D5-E69F-43A7-A896-256995FD8504Q40345527-F9025232-AEB6-4A48-812B-477B0F839FB9Q42121728-B95AD685-13E5-4012-9FBD-2622828790CD
P2860
Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Vaccine-induced immunity in ba ...... iciency virus type 1 gag gene.
@ast
Vaccine-induced immunity in ba ...... iciency virus type 1 gag gene.
@en
type
label
Vaccine-induced immunity in ba ...... iciency virus type 1 gag gene.
@ast
Vaccine-induced immunity in ba ...... iciency virus type 1 gag gene.
@en
prefLabel
Vaccine-induced immunity in ba ...... iciency virus type 1 gag gene.
@ast
Vaccine-induced immunity in ba ...... iciency virus type 1 gag gene.
@en
P2093
P2860
P1433
P1476
Vaccine-induced immunity in ba ...... iciency virus type 1 gag gene.
@en
P2093
Aimin Tang
Daniel C Freed
Danilo R Casimiro
David B Volkin
Denise K Nawrocki
Emilio A Emini
Henryk Mach
John W Shiver
Jose M Aste-Amezaga
Karen Rice
P2860
P304
P356
10.1128/JVI.77.13.7663-7668.2003
P407
P577
2003-07-01T00:00:00Z